Diversified Enterprises’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
2,909
+49
+2% +$23.5K 0.07% 122
2026
Q1
$1.41M Buy
2,860
+57
+2% +$30.9K 0.08% 117
2025
Q4
$1.62M Buy
2,803
+1,392
+99% +$787K 0.1% 90
2025
Q3
$684K Buy
1,411
+22
+2% +$10.2K 0.05% 127
2025
Q2
$563K Sell
1,389
-99
-7% -$41.4K 0.04% 151
2025
Q1
$740K Buy
1,488
+289
+24% +$157K 0.06% 113
2024
Q4
$624K Buy
1,199
+74
+7% +$40.7K 0.06% 111
2024
Q3
$696K Buy
+1,125
New +$666K 0.08% 99

Other funds holding TMO

Diversified Enterprises's TMO Position: Q2 2026 in Review

Diversified Enterprises increased its Thermo Fisher Scientific (TMO) stake by 1.7% in Q2 2026, buying an estimated $23.5K and bringing the position to 2,909 shares worth $1.46M. The position accounts for 0.07% of the portfolio, ranked #122.

Diversified Enterprises first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.62M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Diversified Enterprises held 2,909 shares of Thermo Fisher Scientific worth $1.46M as of Q2 2026.
  • Diversified Enterprises bought 49 Thermo Fisher Scientific shares in Q2 2026, an estimated $23.5K.
  • Thermo Fisher Scientific made up 0.07% of Diversified Enterprises's portfolio in Q2 2026, its #122 holding.
  • Diversified Enterprises first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • Diversified Enterprises's Thermo Fisher Scientific position peaked at $1.62M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.